Completed NA INTERVENTIONAL 1-arm NCT03611491

Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds (FINO)

A Prospective, Open Label, Multicenter, Post Market Study Evaluating Princess® FILLER Lidocaine for the Correction of Nasolabial Folds

Sponsor: Croma-Pharma GmbH

Conditions Correction of Nasolabial Folds

Interventions Princess FILLER Lidocaine

Updated 6 times since 2018 Last updated: Mar 10, 2025 Started: Sep 20, 2017 Primary completion: Nov 19, 2018 Completion: Nov 19, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Correction of Nasolabial Folds, this trial is completed. The trial is conducted by Croma-Pharma GmbH and has accumulated 6 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Apr 2025 — Present [monthly]

Completed NA
Sep 2024 — Apr 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Sep 2018 — Mar 2019 [monthly]

Active Not Recruiting NA

First recorded

Sep 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Croma-Pharma GmbH

Data source: Croma-Pharma GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria